Evidence map›Paper›PMID 33972545›Full record

ArticleNature communications2021

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA.

Fatima Rizvi, Elissa Everton, Anna R Smith, Hua Liu, Elizabeth Osota, Mitchell Beattie, Ying Tam, Norbert Pardi, Drew Weissman, Valerie Gouon-Evans

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Fatima Rizvi *Center for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA.ORCID http://orcid.org/0000-0002-9157-7635
Elissa Everton *Center for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA.ORCID http://orcid.org/0000-0003-3837-4924
Anna R SmithCenter for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA.ORCID http://orcid.org/0000-0001-9552-6176
Hua LiuCenter for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA.
Elizabeth OsotaCenter for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA.
Mitchell BeattieAcuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada.
Ying TamAcuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada.
Norbert PardiDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Drew WeissmanDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Valerie Gouon-EvansCenter for Regenerative Medicine and the Section of Gastroenterology of Boston University and Boston Medical Center, 670 Albany street, Boston, MA, 02118, USA. valerige@bu.edu.ORCID http://orcid.org/0000-0001-5424-6573

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
A National iPS Cell Network with Deep Phenotyping for Translational ResearchU01TR001810 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILAD, YOAV, KOTTON, DARRELL N. · 2016 to 2020
$4.4M
NRSA Training CoreTL1TR001410 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N. · 2015 to 2024
$4.3M
A National Resource for Lung disease-specific iPS cellsR24HL123828 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N., MOSTOSLAVSKY, GUSTAVO · 2014 to 2018
$2.7M
A multi-modular approach for human pluripotent stem cell-based liver regenerationR01DK124361 · NIDDK · BOSTON MEDICAL CENTER · PI GOUON-EVANS, VALERIE B · 2020 to 2023
$2.2M
In Vivo Imaging Analysis System - Xenogen IVIS SpectrumS10RR024523 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2008 to 2008
$350k
NCATS NIH HHS TL1 TR001410NCATS NIH HHS U01 TR001810NCATS NIH HHS UL1 TR001430NCRR NIH HHS S10 RR024523NHLBI NIH HHS R24 HL123828NIDDK NIH HHS R01 DK124361
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33972545
PMCPMC8110992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.